Release Details

vTv Therapeutics to Present at Two Upcoming Annual Investor Conferences

March 10, 2017
PDF Version

HIGH POINT, N.C.--(BUSINESS WIRE)--Mar. 10, 2017-- vTv Therapeutics Inc. (vTv) (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, among other therapeutic areas, today announced that company management will present a corporate overview at two upcoming investor conferences.

Presentation Details:

ROTH Capital Partners 29th Annual Growth Stock Conference

  • Location: Dana Point, California
  • Presentation Date: Tuesday, March 14, 2017
  • Presentation Time: 7:30 am PT

Needham & Co. 16th Annual Healthcare Conference

  • Location: New York, New York
  • Presentation Date: Tuesday, April 4, 2017
  • Presentation Time: 4:20 pm ET

Live webcasts of the presentations can be accessed on the News & Events section of the website. The webcasts will be archived for 30 days following the presentations on the Company’s website at www.vtvtherapeutics.com.

About vTv Therapeutics

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

Source: vTv Therapeutics Inc.

vTv Therapeutics Inc.
Michael Gibralter, 646-378-2938
IR@vtvtherapeutics.com
or
Media:
Pure Communications Inc.
Katie Engleman, 910-509-3977
Katie@purecommunicationsinc.com